StudyFinder

Prospective, Multicenter, Single-Arm Study of VanquishTM Water Vapor Ablation for PrOstate CanceR

Recruiting

The purpose of this study is to determine the safety and efficacy of the Vanquish System treatment in men who have intermediate risk prostate cancer. In this study, the Vanquish System will be used to destroy cancerous tissue in the prostate. After treatment, participants will undergo tests that will assess presence of prostate cancer.

I'm interested

Male
18 years and over
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• 50 years or older
• PSA no more than 15 ng/ml
• cancer stage less than or equal to T2c
• had a multiparametric MRI within the last 12 months and MRI software guided fusion biopsy of the prostate within the last 6 months
Exclusion Criteria:

• prior surgery, intervention, or minimally invasive therapy, for the prostate cancer or bladder neck
• taking medications that have hormonal effects on the prostate or PSA or or testosterone supplement
• significant medical or mental health diagnosis (study staff will review)

Device: Vanquish System

Cancer, Kidney, Prostate & Urinary

Clinics and Surgery Center (CSC), Prostate Cancer, Prostate Cancer

Maressa Twedt - twedt050@umn.edu
Christopher Warlick, MD
NA
STUDY00019145
See this study on ClinicalTrials.gov

Back